Market revenue in 2023 | USD 173.0 million |
Market revenue in 2030 | USD 245.0 million |
Growth rate | 5.1% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Oncology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases |
Key market players worldwide | Roche, Abbott Laboratories, Qiagen NV, Bayer AG, Nova Biomedical, Danaher Corp, Nipro Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc, BioMerieux SA, OraSure Technologies Inc, Abaxis |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 93.58% in 2023. Horizon Databook has segmented the Italy point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
The increase in demand for rapid diagnostic procedures and the prevalence of chronic diseases in Italy are key drivers of its point-of-care molecular diagnostics market. A large number of manufacturers and distributors offer essential instruments, kits, and reagents for molecular diagnostics, which is expected to boost market growth. Siemens Healthcare GmbH, Roche Diagnostics, and DiaSorin are some key companies operating in Italy.
R&D activities are anticipated to accelerate, owing to increased funding offered by government & nongovernment organizations. The demand for automated infectious diseases molecular diagnostics is growing in the country, which can be attributed to the difficulty in hiring staff for diagnostic laboratories. This creates lucrative growth opportunities for automated molecular diagnostics companies to increase their market share and revenue.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy point-of-care molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Italy point-of-care molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account